Trial Search Results

Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status

To compare the effectiveness of usual treatments for lymphedema [massage and elastic compression sleeve, instituted at-risk and before the development of swelling (lymphedema)], compared to the use of a newly-marketed device, the Flexitouch, which electronically simulates the effect of massage upon lymph flow.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Device: Flexitouch
  • Device: Class 1 compression garment




Inclusion Criteria:

   - Unilateral breast cancer

   - Scheduled to undergo breast surgery and axillary lymph node dissection, with or
   without breast conserving techniques.

   - Referred to the surgeons of the Stanford University Breast Cancer Program

   - Capacity to provide informed consent.

   - All experimental protocols will be reviewed and approved by the Stanford Institutional
   Review Board for the Protection of Human Subjects.

Exclusion Criteria:

   - Other serious systemic illness (renal failure, hepatic dysfunction, congestive heart
   failure, neurological or psychological impairment) that would confound the study or
   impair the patients' ability to participate.

   - Recurrent breast cancer or other forms of pre-existing lymphedema.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Les Roche, RN